Use in pregnancy: No fetal toxicity or malformation has been reported. However, follow-up of women exposed to sulbutiamine during pregnancy is insufficient to exclude such a risk. Therefore, as a precautionary measure, it is preferable not to use this drug during pregnancy.
Use in lactation: In the absence of data concerning the diffusion into breast milk, breastfeeding is not recommended during treatment.
Other Services
Country
Account